Single versus double intensive remissions therapy: preliminary results of randomized studies.
| . | . | . | EFS . | OS . | ||||
|---|---|---|---|---|---|---|---|---|
| . | No. of Pts . | Median Follow-up . | Single . | Double . | p value . | Single . | Double . | p value . |
| IFM 94 (22) | 403 | 5Y | at 5 yr 17% | 27% | 0.06 | at 5 yr 40% | 48% | NS |
| HOVON (23) | 255 | 29 M | at 3 yr 35% | 36% | NS | at 4 yr 47% | 43% | NS |
| BOLOGNA 96 (24) | 178 | 30 M | (med) 21 m | 29 | NS | at 4 yr 74% | 71% | NS |
| MAG (25) | 193 | 27 M | 41 events | 43 events | NS | 27 deaths | 22 deaths | NS |
| . | . | . | EFS . | OS . | ||||
|---|---|---|---|---|---|---|---|---|
| . | No. of Pts . | Median Follow-up . | Single . | Double . | p value . | Single . | Double . | p value . |
| IFM 94 (22) | 403 | 5Y | at 5 yr 17% | 27% | 0.06 | at 5 yr 40% | 48% | NS |
| HOVON (23) | 255 | 29 M | at 3 yr 35% | 36% | NS | at 4 yr 47% | 43% | NS |
| BOLOGNA 96 (24) | 178 | 30 M | (med) 21 m | 29 | NS | at 4 yr 74% | 71% | NS |
| MAG (25) | 193 | 27 M | 41 events | 43 events | NS | 27 deaths | 22 deaths | NS |